Dialysis vs conservative management decision aid: a study protocol by Winterbottom, AE et al.
This is a repository copy of Dialysis vs conservative management decision aid: a study 
protocol.
White Rose Research Online URL for this paper:
http://eprints.whiterose.ac.uk/159372/
Version: Accepted Version
Article:
Winterbottom, AE orcid.org/0000-0002-1206-9430, Bekker, HL, Russon, L et al. (4 more 
authors) (2018) Dialysis vs conservative management decision aid: a study protocol. 
Journal of Kidney Care, 3 (3). pp. 179-185. ISSN 2397-9534 
10.12968/jokc.2018.3.3.179
This document is the Accepted Manuscript version of a Published Work that appeared in 
final form in Journal of Kidney Care copyright © MA Healthcare, after peer review and 
technical editing by the publisher. To access the final edited and published work see 
http://dx.doi.org10.12968/jokc.2018.3.3.179
eprints@whiterose.ac.uk
https://eprints.whiterose.ac.uk/
Reuse 
Items deposited in White Rose Research Online are protected by copyright, with all rights reserved unless 
indicated otherwise. They may be downloaded and/or printed for private study, or other acts as permitted by 
national copyright laws. The publisher or other rights holders may allow further reproduction and re-use of 
the full text version. This is indicated by the licence information on the White Rose Research Online record 
for the item. 
Takedown 
If you consider content in White Rose Research Online to be in breach of UK law, please notify us by 
emailing eprints@whiterose.ac.uk including the URL of the record and the reason for the withdrawal request. 
1	
	
Abstract		
Background:	When	 patients’	 kidney	 function	 deteriorates	 to	 Chronic	 Kidney	 Disease	 Stage	 5,	
services	 offer	 patients	 a	 choice	 for	 the	 next	 phase	 of	 their	 care	 –	 conservative	 management	
(diet/fluid/medication)	 or	 renal	 replacement	 therapy	 (dialysis/transplant).	 Dialysis	 may	 not	
have	survival	benefits,	and	conservative	management	may	have	less	treatment	burden,	for	older	
patient	 groups	 with	 associated	 co-morbidities	 or	 frailty.	 Kidney	 professionals	 recognise	 the	
need	for	training	and	resources	to	support	patients	making	treatment	decisions	that	fit	best	into	
their	lifestyle,	consistently	across	UK	services.	
Aim:	To	develop	an	evidence-based	patient	decision	aid	for	services	to	use	with	patients	when	
making	informed	decisions	between	conservative	management	and	dialysis	care	pathways.	
Methods:	Surveys	a)	identifying	service	need	using	an	environmental	scan	of	written	resources,	
and	 interviews	with	staff	and	patients	about	current	practice,	b)	assess	 the	Yorkshire	Dialysis	
and	 conservative	 management	 decision	 aid	 (YoDCA)	 acceptability	 in	 practice	 to	 staff	 and	
patients	using	observational	and	questionnaire	methods.	
	
Keywords		
Patient	decision	aid,	conservative	management,	dialysis,	shared	decision	making.	
	
Key	points		
¥ When	patients	 transition	 from	chronic	kidney	disease	 to	kidney	 failure,	 services	begin	
conversations	 with	 patients	 to	 plan	 for	 the	 next	 treatment	 phase	 offering	 either	 a	
conservative	management	or	a	renal	replacement	pathway	(dialysis	and/or	transplant).	
¥ There	may	be	no	survival	benefit	of	dialysis	versus	conservative	management	for	certain	
elderly	 patient	 groups,	 and	 the	 burden	 of	 dialysis	 treatment	 means	 conservative	
management	may	be	a	better	option	for	some	patients.	
¥ Building	 on	 our	 previous	 highly	 successful	 work	 in	 this	 field,	 we	 will	 develop	 the	
Yorkshire	 Dialysis	 vs	 Conservative-management	 decision	 aid	 (YoDCA)	 to	 promote	
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informed	decision	making	between	conservative	management	and	dialysis	 for	patients	
with	chronic	kidney	disease	during	consultations	with	health	care	professionals.	
¥ Patient	decision	aids	are	resources	to	support	patients	making	decisions	by	drawing	on	
evidence	of	 how	 to	help	people	deliberate	 about	 treatment	 information	 in	 accordance	
with	their	personal	circumstances.	
¥ A	 supporting	 training	 package	 will	 be	 developed	 which	 focusses	 on	 providing	 health	
professionals	 with	 resources	 to	 enable	 the	 conversation	 about	 conservative	
management	and	facilitate	decision	making.	
	
Reflective	questions	
1. How	 do	 patients	 think	 about	 changes	 in	 their	 disease	 state	 when	 clinical	 markers	
indicate	a	progression	from	kidney	disease	to	kidney	failure?		
2. When	 should	 staff	 begin	 discussions	 about	 the	 conservative	 management/dialysis	
treatment	decision	with	their	patients?	
3. What	do	patients	need	 to	know	about	 their	 illness	and	 treatment	options	 for	 the	next	
phase	of	their	illness	to	make	informed	decisions	about	their	short	and	longer	term	care	
plans?	
4. What	 are	 the	 training	 needs	 of	 staff	 to	 successfully	 support	 patients	 at	 this	 transition	
point?	
5. How	do	we	effectively	integrate	a	patient	decision	aid	for	the	conservative	management	
/dialysis	decision	into	clinical	practice?		
	 	 	 	 	
Background	
A	transition	point	for	the	management	of	patients	with	worsening	kidney	disease	occurs	when	
kidney	 function	 deteriorates	 to	 Chronic	 Kidney	 Disease	 (CKD)	 Stage	 5.	 Services	 begin	
conversations	with	patients	to	plan	for	the	next	treatment	phase	offering	either	a	conservative	
management	(CM)	pathway	(changing	diet/fluid	and	medication	regimens	to	control	increasing	
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symptoms)	or	a	renal	replacement	pathway	(RRT;	adding	dialysis	and/or	transplant	options	to	
maintain	 some	 functions	 normally	 undertaken	 by	 the	 kidneys).	When	 renal	 transplant	 is	 not	
medically	appropriate,	dialysis	treatment	(DT)	has	been	offered	as	the	most	clinically	effective	
treatment	option.	The	age	of	patients	receiving	RRT	has	increased	significantly	over	the	last	25	
years	with	 the	 take-on	 rate	of	 those	>65	over	 twice	 the	 take	on	 rate	of	 those	younger	 (Renal	
Registry,	 1998,	 2016),	 meaning	 patients	 starting	 DT	 are	 more	 likely	 to	 have	 co-morbidities,	
increased	 symptom	burden	and	 likelihood	of	 being	 frail	 (Combs	&	Davison,	 2015).	Data	 from	
our	Leeds	unit	 suggests	 there	may	be	no	 survival	 benefit	 of	DT	versus	CM	 for	 certain	 elderly	
patient	groups	(Hussain,	Mooney	&	Russon,	2013),	 and	 the	burden	of	DT	means	CM	may	be	a	
better	option	for	some	patients	(Farrington	et	al	2017;	Foote	et	al,	2014).	
Pre-dialysis	education	is	central	to	empowering	patients	to	make	treatment	choices	effectively	
(Hainsworth,	 2004;	 NICE,	 2008).	 There	 is	 variation	 in	 how	 services	 deliver	 pre-dialysis	
education	 in	 the	 UK,	 and	 how	 CM	 is	 offered	 within	 pre-dialysis	 services	 (Gunda,	 Thomas	 &	
Smith	2005).	Some	frame	CM	as	a	 ‘non-dialysis’	option	(passive)	and/or	as	part	of	a	palliative	
care	 pathway	 (Murtagh,	 2016;	 Roderick	 et	 al,	 2015)..	Further,	 ‘advanced	 care	 planning’	 –	 the	
discussion	of	future	plans	for	patients	preferences	about	issues	such	as	symptom	management,	
quality	of	life	and	treatment	preferences	towards	the	end	of	life	(Davison	&	Torgunrud	2007)	-	
is	typically	only	discussed	with	patients	who	opt	for	CM	(Holley	&	Davison,	2015;	Janssen	et	al	
2013).	Palliative	care	and	end	of	 life	planning	are	options	that	should	be	made	available	to	all	
patients	with	End	Stage	Kidney	Disease	(ESKD),	alongside	their	DT	and	CM	regimens.	Hussain	
and	 colleagues	 (2015)	 reported	 that	 19.7%	of	 patients	 died	before	 commencing	dialysis	 over	
their	4	year	study	period,	highlighting	the	importance	of	advanced	care	planning	in	this	group.		
Staff	 recognise	 a	 need	 for	more	 training	 and	 resources	 to	 help	 them	discuss	 CM	 as	 an	 active	
option	with	patients	(Bristowe	et	al	2014,	Fortnum	et	al	2015).	They	report	a	need	for	balanced	
information	on	the	benefits	and	risks	of	both	CM	and	dialysis,	impact	on	patients’	quality	of	life,	
carer	 burden,	 and	 end	 of	 life	 care	 planning	 (Noble	 et	 al	 2009).	 Patients	 with	 ESKD	 report	
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wanting	 more	 guidance	 in	 making	 treatment	 decisions	 (Hussain	 et	 al,	 2015),	 and	 at	 earlier	
phases	 in	 their	 care	 pathway	 (Wright	 Nunes	 et	 al,	 2016),	 yet	 doctors	 feel	 unprepared	 for	
discussing	end	of	life	issues	with	patients	(Schell	&	Cohen,	2014;	Schell	et	al,	2012).	To	support	
patients	 to	 make	 reasoned	 decisions	 between	 options,	 staff	 need	 to	 present	 balanced	 and	
equitable	information	about	options	and	their	consequences.	This	enables	patients	to	evaluate	
these	details	with	their	beliefs,	and	help	patients	trade-offs	the	preference	that	fits	best	in	their	
lives	(Bekker	et	al,	1999;	Winterbottom	et	al,	2016).		
Patient	 Decision	 Aids	 (PtDAs)	 are	 resources	 that	 support	 people	 to	 make	 more	 informed	
decisions	between	treatment	options	than	those	receiving	usual	care	(Bekker	et	al,1999,	2015;	
Bekker,	 2010,	 Winterbottom	 et	 al,	 2016).	 PtDAs	 are	 evidence-based,	 drawing	 on	 decision	
science	 studies	 to	 identify	 components	 that	 boost,	 or	 bias,	 people’s	 thinking	 (Bekker,	 2013;	
2010;	 Volk	 et	 al,	 2013).	 We	 established	 that	 patients	 represent	 the	 ‘dialysis	 decision’	 as	 a	
hierarchy	 of	 nested	 choices,	 i.e.	 first	 the	 dialysis	 versus	 ‘no	 dialysis’	 decision,	 and	 second	 the	
‘between	dialysis	modalities’	decision	(see	Figure	1;	Winterbottom	et	al,	2014).	We	developed	
The	Dialysis	Decision	Aid	Booklet	(Bekker	et	al,	2015)	to	support	people	with	worsening	kidney	
disease	 make	 informed	 decisions	 between	 the	 second	 of	 these	 choices	 -	 the	 choice	 between	
dialysis	modalities	(Winterbottom	et	al,	2016).	It	was	not	designed	to	help	people	think	about	
whether	or	not	to	have	dialysis,	although	this	decision	was	signposted.	The	reasons	people	give	
in	 retrospect	 for	 deciding	 between	 CM	 and	 dialysis	 are	 varied	 and	 include	 patient	 lifestyle,	
treatment	 preferences,	 healthcare	 and	 end	 of	 life	 perceptions;	 communication	 and	 service	
delivery	 (Morton	 et	 al,	 2012).	 People	 identify	 attributes	 important	 to	 them	 for	 their	 decision,	
and	 they	 trade-off	 what	 is	 important	 to	 them.	 However	 it	 is	 unclear	 how	 to	 present	 this	
information	 neutrally	 and	 in	 a	 way	 that	 supports	 people	 to	 reason	 proactively	 between	 the	
‘dialysis	treatment’	and	‘CM’	options,	before	making	a	choice.	Several	patient	resources	present	
CM	 as	 an	 option	 for	 comparison	 alongside	 three	 renal	 replacement	 options	 (haemodialysis,	
peritoneal	dialysis	and	transplant;	e.g.	Pritchard	&	Thomas,	2013;	Rightcare,	2012).	 It	 is	 likely	
this	presentation	weights	the	content	of	the	resource	towards	preparing	for	RRT,	rather	than	as	
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a	way	of	helping	people	consider	which	option	best	suits	them	when	adapting	their	lifestyle	to	
advancing	kidney	disease	and	worsening	health	state	(Shafir	et	al,	1994).	
<Figure	1	about	here>	
This	Kidney	Research	Yorkshire	 (ref:	KRY	16-118)	 funded	project	will	 carry	 out	 the	 research	
needed	to	a)	develop	a	PtDA	for	kidney	services	to	use	with	patients	making	informed	decisions	
between	CM	and	dialysis	care	pathways,	and	b)	assess	its	acceptability	in	renal	services.		
Methods	
All	aspects	of	the	research	are	discussed	with	the	steering	group.	A	patient	representative	will	
attend	 steering	 group	 meetings	 and	 provide	 input/feedback	 throughout	 the	 project	 as	
appropriate	e.g.	reviewing	patient	information	sheets/protocol	submission/interview	schedules.	
The	study	 is	awaiting	Health	Research	Authority,	under	 review	by	 the	Yorkshire	and	Humber	
National	 Research	 Ethics	 Committee	 (re:	 IRAS231121,	 Dec	 2017)	 and	 National	 Institute	 for	
Health	Research	(NIHR)	Clinical	Research	Network	approval.	
	
Aims	and	objectives	
This	research	will	develop	a	 theoretically	driven,	evidence	based	resource	to	support	patients	
with	 CKD	 choosing	 between	 conservative	 management	 and	 dialysis	 treatment	 options	 in	
consultation	with	health	professionals.	The	objectives	are	to:	
¥ Ensure	the	PtDA	content	is	accurate,	complete	and	relevant	to	patients	by	conducting	a	
needs	assessment	examining	the	sufficiency	of	patient	resources	(Phase	1).	
¥ Establish	 the	 clinical	 context	 and	 challenges	 to	 developing	 the	 PtDA	 using	 interviews	
and	observational	methods	(Phase	2).	
¥ Develop	 the	 PtDA	 using	 guidelines	 to	 inform	 the	 content,	 frameworks	 for	 their	
development	and	our	experience	of	investigating	patient	decision	making	about	dialysis	
(Phase	3).	
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¥ Develop	 a	 staff	 training	 package	 to	 support	 health	 professionals	 use	 of	 the	 PtDA	 and	
assess	 it’s	 acceptability	 in	 clinical	 practice	 using	 interviews,	 focus	 groups	 and	
observational	methods	(Phase	4).		
	
Design	
This	is	a	prospective	observational	study	employing	survey	methods.	There	are	distinct	phases	
to	developing,	 evaluating	and	 implementing	 complex	 interventions	 (Medical	Research	Council	
(MRC),	2008;	Coulter	et	al,	2013).	The	plan	of	 investigation	 for	 this	PtDA	 falls	within	 the	 first	
phase:	developing	and	modelling	prior	to	formal	evaluation.		
	
Phase	1:	Needs	Assessment	(September	2017	–	February	2018)	
To	ensure	that	the	PtDA	content	is	accurate,	complete	and	relevant	to	patients	we	will	conduct	
an	environmental	scan	to	examine	the	sufficiency	of	patient	resources	to	support	this	decision.	
Environmental	scans	are	tools	for	retrieving	and	organizing	data	from	a	wide	variety	of	sources.	
They	are	broader	than	systematic	reviews	in	that	they	are	capable	of	identifying	work	that	may	
not	have	been	subject	to	a	published	evaluation	(Graham	et	al,	2008).	
Audit	of	written	patient	information	
Sample	–	A	survey	of	all	UK	renal	units	and	national	UK	kidney	charities.		
Materials	-	A	questionnaire	designed	for	purpose	asking	about	provision	of	patient	information	
for	DT/CM	choice.	A	coding	 frame	will	be	developed	with	reference	 to	 renal	policy	guidelines	
and	checklists	of	content,	style	and	formatting	known	to	be	associated	with	written	information	
quality	 and	 decision-making	 facilitation.	 These	 materials	 will	 be	 adapted	 from	 our	 work	
surveying	dialysis	information	(Winterbottom	et	al,	2007).		
Data	 collection	 –	 Renal	 units	 will	 receive	 a	 copy	 of	 the	 questionnaire	 by	 post.	 Completed	
surveys	will	be	returned	in	a	SAE	along	with	any	relevant	copies	of	written	patient	information.	
Requests	for	patient	information	will	be	sent	via	email	to	UK	kidney	charities.	
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Data	 analysis	 –	 Questionnaire	 and	 coding	 frame	 data	 will	 be	 summarised	 using	 descriptive	
statistical	analysis.	For	each	item	in	the	coding	frame,	a	leaflet	could	score	‘0’	or	‘1’,	‘1’	if	the	item	
appeared	in	the	leaflet.	The	overall	leaflet	quality	score	will	be	calculated	by	adding	up	all	items.	
Statistical	analysis	will	be	conducted	using	SPSS	version	22	(IBM	Corporation,	Armonk,	NY).		
a) Quality	assessment	of	PtDAs	that	include	CM	as	a	treatment	choice	
We	 will	 critically	 evaluate	 the	 strengths	 and	 weaknesses	 of	 decision	 support	 interventions	
designed	for	this	decision	context.		
Sample	 -	 PtDAs	 published	 internationally	 comparing	 treatment	 options	 for	 patients	 with	
CKD/ESKD.	
Materials	 –	 Data	 extraction	 form	 developed	 for	 purpose	 and	 informed	 by	 our	 past	 work	 in	
dialysis	 decision	 making	 and	 PtDA	 research	 (Bekker	 et	 al,	 1999,	 2013;	 Winterbottom	 et	 al.,	
2007;	Sepucha	et	al.,	2017),	including	IPDASv4	checklist	for	assessing	PtDA	quality	(Volk	et	al,	
2013).	
Data	 collection	 –	 PtDAs	 will	 be	 selected	 from	 literature	 searches	 and	 contact	 with	 leading	
researchers	 in	 the	 field.	 For	 each	 PtDA	 key	 characteristics	 (e.g.	 treatment	 options	 described,	
description	 of	 health	 issue)	 will	 be	 identified	 and	 extracted	 systematically	 using	 the	 data	
extraction	 form.	 Two	 judgments-of-resource-quality	 grids	will	 be	 applied:	 IPDAS	 criteria	 grid	
describing	 12	 criteria	 identified	 as	 minimum	 standards	 for	 inclusion	 within	 patient	 decision	
aids	(Joseph-Williams,	2014);	 informed	decision	making	(IDM)	grid	describing	10	components	
known	to	boost	active,	and	minimise	biases	in	reasoning	(Bekker	et	al,	1999;	Bekker	et	al	2003;	
2010).	Each	item	scored	either	0	(not	present)	or	1	(present);	total	scores	calculated	by	adding	
all	items,	ranging	from	0-12	(IPDAS	grid)	and	0-10	(IDM	grid).	
Data	analysis	-	The	lead	researcher	(AW)	will	perform	the	quality	assessment	and	data	will	be	
discussed	with	team	members	(HB	&	AM)	to	ensure	its	validity.		
Data	 will	 be	 analysed	 using	 SPSS	 (version	 22)	 and	 summarised	 using	 descriptive	 statistical	
analysis.		
b) Review	of	evidence:	to	include	renal	guidelines	to	identify	risks,	benefits	and	
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effectiveness	 of	 CM/DT	 (NICE,	 2008),	 service	 frameworks;	 existing	 patient	 information;	
patient/professional	surveys	of	CM/DT	choices	(e.g.	Morton	et	al,	2010;	van	Biesen	et	al,	2014;	
Caskey	2016);	 behavioural	 decision	 support	 guidance	 and	 frameworks	 for	PtDA	development	
(Joseph-Williams	 et	 al,	 2014);	 our	 experience	 of	 investigating	 patient	 decision	making	 about	
dialysis	(Winterbottom	et	al,	2007,	2012,	2014,	2016).		
	
Phase	2:	Establishing	the	clinical	context	(March	2018	–	August	2018)	
Sample	and	recruitment	–	A	purposive	sample	of	adult	patients	with	kidney	disease	to	include	
those	at	any	stage	of	decision	making	about	CM	or	DT,	including	those	who	change	their	mind	
and/or	late	referrals;	new	and	established	patients	receiving	DT/CM	treatments	including	those	
who	have	 switched	 treatments;	 and	 staff	who	oversee	 and	manage	 the	 care	 of	 these	 patients	
will	 be	 invited	 to	 take	 part.	 Exclusion	 criteria:	 adults	 unable	 to	 speak	 English	 and/or	 those	
lacking	 cognitive	 capacity	 to	 take	 part	 in	 an	 interview.	 Participants	 will	 be	 recruited	 and	
consented	at	outpatient	clinics	at	 the	Adult	Renal	Unit,	St	 James	University	Hospital,	Leeds	by	
research	nurses/project	manager.		
Study	materials	 -	Study	 information	 sheets,	 consent	 forms	 to	 inform	and	 recruit	 participants	
and	an	interview	guide	for	staff	and	patients	are	developed.		
Data	collection	–	from	two	sources:		
a) Semi-structured	 interviews	with	staff,	patient	and	carers	will	 elicit	 views	 about	 how	 to	
make	 sense	 of	 CKD	 and	 changes	 to	 management	 over	 time	 using	 current	 PtDAs	 as	
prompts.	 Staff	 will	 be	 interviewed	 about	 how	 they	 support	 patient’s	 decisions	 with	
transitions	 in	 CKD	 between	 different	 treatment	 pathways	 (CM/DT/withdrawal)	 and	
discuss	 training	needs.	 Interviews	will	be	conducted	by	project	manager	(AW),	 last	no	
longer	 than	 60	 minutes	 and	 take	 place	 at	 a	 location	 suitable	 to	 the	 participant	
(home/hospital).	
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b) Audio-recorded	 consultations	 between	 health	 professionals	 and	 patients	 will	 explore	
current	 practice	 in	 terms	 of	 how	 options	 are	 introduced	 and	 discussed	 and	 further	
identify	training	needs.	Consultations	last	approximately	20-30	minutes.	
Data	analysis	 -	 Interviews	 and	 observations	will	 be	 tape	 recorded,	 transcribed	 and	 analysed	
using	 a	 thematic	 analysis	 (Braun	&	Clarke,	 2006).	Data	 collection	will	 be	 continued	until	 it	 is	
judged	no	new	themes	are	emerging	from	data	(saturation).	Interviewing	about	30	patients	and	
staff	and	observing	approximately	10	consultations	should	be	sufficient	(Richie	&	Lewis,	2005).	
	
Phase	3:	Development	of	the	PtDA	(September	2018	–	November	2018)		
The	information	included	in	the	PtDA	will	be	structured	so	that	it	encourages	people	to	evaluate	
all	 decision	 options	 and	 their	 consequences	 in	 accordance	with	 their	 values,	 to	 help	 patients	
made	trade-offs	about	treatments	 in	discussion	with	kidney	professionals	(Bekker	et	al,	1999;	
Winterbottom	et	 al,	 2016).	 The	PtDA	will	 be	developed	 in	paper	 format	 only;	 content	will	 be	
informed	by	phase	1&2	and	also	include:	
¥ Guidelines	on	the	development	of	complex	interventions	to	ensure	that	text	is	readable	
(Coulter	et	al	1998),	language	used	is	accurate	and	value-free	(Bekker	et	al,	2009),	risks	
are	presented	in	numeric	and	pictorial	form	to	aid	understanding	(Lipkus,	2007).	Value	
clarification	 tasks	 (Stigglebout,	 2000)	 will	 help	 patients	 unpack	 the	 choices	 in	 this	
decision.	 Technical	 details	 will	 be	 packaged	 within	 phrases	 that	 help	 patients	 make	
sense	of	the	treatments	within	their	representation	of	kidney	disease	(Timmers,	2008).		
¥ Regular	 meetings	 with	 study	 steering	 group	 to	 decide	 the	 content	 and	 design	 of	 the	
PtDA.		
	
Phase	4:	Staff	training	and	implementation	package	development	(December	2018	–	June	
2018)		
We	will	 develop	 and	 pilot	 a	 staff	 training	 package	 for	 use	 in	 conjunction	with	 the	 PtDA.	 The	
training	package	will	ensure	that	the	PtDA	is	practicable	within	the	clinic	setting	and	helps	staff	
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implement	decisions	made	 in	 consultation	with	patients	across	hospital	 systems	and	 in	 inter-
professional	 communication.	 We	 will	 draw	 on	 current	 training	 guidelines/existing	 training	
packages	(Diouf	et	al,	2016)	and	evidence	 from	 interviews	with	staff	 (phase	2)	about	 training	
needs	and	assess	its	acceptability	for	use	in	clinical	practice.	
Sample	and	recruitment	–	Staff,	patients	and	carers	will	be	recruited	from	the	Adult	Renal	Unit,	
St	James	Hospital,	Leeds	and	consented	to	the	study	by	research	nurses/project	manager	(AW).	
Materials	–	Study	information	sheets	and	consent	forms	to	inform	Staff,	patients	and	carers	of	
the	 studies	 and	 to	 recruit	 them	 to	 take	 part	 have	 been	 developed.	 The	 PtDA	 and	 training	
package	will	be	included	for	use.	
Data	collection	–	Data	will	be	collected	from	two	sources:	
a) Focus	 groups	 with	 staff	 to	 provide	 feedback	 on	 resource	 development	 and	 identify	
changes	 in	 system	 factors	 to	 ensure	 the	 resource	 can	 be	 integrated	 into	 existing	
operating	procedures	to	allow	inter-professional	communication	across	services.	
b) Audio-recorded	consultations	between	health	professionals	and	their	patients	 and	 carers	
will	explore	how	the	PtDA	is	used	in	practice	and	identify	barriers	and	facilitators	to	use	
as	well	as	identify	further	training	needs.	Each	consultation	will	last	approximately	20-
30	minutes.	
Data	analysis	-	Focus	groups	and	observations	will	be	tape	recorded,	transcribed	and	analysed	
using	a	thematic	analysis.	Approximately	30	staff	will	be	invited	to	take	part	and	approximately	
10	clinic	observations/recordings	should	be	sufficient.		
Discussion	
Staff	and	patients	require	more	support	with	the	CM/DT	decision	in	terms	of	how	and	when	it	is	
discussed	as	patient’s	transition	from	CKD	to	ESKD.	The	PtDA	will	provide	health	professionals	
with	a	resource	and	implementation	package	to	facilitate	this	discussion	during	the	consultation.	
This	should	improve	patients’	experience	and	participation	in	their	care	by	providing	a	tailored	
approach	 through	 the	 development	 a	 theory	 driven,	 evidence-based	 resource.	 It	 should	 also	
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increase	 patient	 uptake	 of	 the	most	 appropriate	 treatment	 option	 allowing	 efficient	 resource	
allocation	and	 lead	 to	patients	 receiving	appropriate	management	 for	 their	ESKD	by	enabling	
patient	 preferences	 to	 be	 integrated	 into	 care	 planning.	Whilst	 this	 research	will	 not	 provide	
evidence	of	the	PtDAs	effectiveness	on	healthcare	outcomes	our	findings	will	provide	evidence	
to	inform	the	study	design	for	evaluating	the	effectiveness	of	this	complex	intervention	and	this	
will	 form	 the	 basis	 of	 future	 grant	 applications.
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